• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥利什曼原虫亚马逊亚种感染小鼠中的T细胞反应:CD8⁺细胞产生γ干扰素

T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.

作者信息

Chan M M

机构信息

Department of Biological Sciences, Rutgers, State University of New Jersey, Piscataway 08855-1059.

出版信息

Eur J Immunol. 1993 May;23(5):1181-4. doi: 10.1002/eji.1830230532.

DOI:10.1002/eji.1830230532
PMID:8097471
Abstract

The immune response to Leishmania major has been the subject of many investigations. However, Leishmania includes many species with different clinical manifestations. In this report, we studied the T cell response to L. mexicana amazonensis, a New World species, in a murine model. We found that, similar to L. major, an Old World species, resistant C57BL/6 mice produced a high level of IFN-gamma and a low level of IL-4. Conversely, susceptible BALB/c mice produced a much lower level of IFN-gamma and higher level of IL-4. Although IFN-gamma is one of the important lymphokines that mediate macrophage activation and thus the destruction of the intracellular parasites, which lymphocyte subsets are producing the IFN-gamma is still a controversy. Much evidence including the isolation of protective, IFN-gamma-producing, CD4+ cell lines have confirmed the participation of CD4+ Th1 cells unequivocally. However, both CD4+ and CD8+ cells produced IFN-gamma. Recently, an increasing body of evidence has appeared suggesting that CD8+ cells also play a role in the resolution of murine L. major infection. We found that in the L. m. amazonensis model, when CD8+ lymphocytes from resistant C57BL/6 mice were eliminated by anti-CD8 antibody and complement-mediated lysis, the IFN-gamma production was reduced by 77%. This indicated that CD8+ cells produced a significant amount of the IFN-gamma. However, our results also indicate that IFN-gamma production by CD8+ cells was dependent on CD4+ cells.

摘要

对硕大利什曼原虫的免疫反应一直是众多研究的主题。然而,利什曼原虫包括许多具有不同临床表现的物种。在本报告中,我们在小鼠模型中研究了对墨西哥利什曼原虫亚马逊亚种(一种新大陆物种)的T细胞反应。我们发现,与旧大陆物种硕大利什曼原虫类似,具有抗性的C57BL/6小鼠产生高水平的干扰素-γ和低水平的白细胞介素-4。相反,易感的BALB/c小鼠产生的干扰素-γ水平低得多,而白细胞介素-4水平高得多。虽然干扰素-γ是介导巨噬细胞活化从而破坏细胞内寄生虫的重要淋巴因子之一,但产生干扰素-γ的淋巴细胞亚群仍存在争议。包括分离出具有保护性、产生干扰素-γ的CD4+细胞系在内的许多证据明确证实了CD4+ Th1细胞的参与。然而,CD4+和CD8+细胞都能产生干扰素-γ。最近,越来越多证据表明CD8+细胞在小鼠硕大利什曼原虫感染的消退中也发挥作用。我们发现在墨西哥利什曼原虫亚马逊亚种模型中,当用抗CD8抗体和补体介导的溶解作用清除抗性C57BL/6小鼠的CD8+淋巴细胞时,干扰素-γ的产生减少了77%。这表明CD8+细胞产生了大量的干扰素-γ。然而,我们的结果也表明CD8+细胞产生干扰素-γ依赖于CD4+细胞。

相似文献

1
T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.墨西哥利什曼原虫亚马逊亚种感染小鼠中的T细胞反应:CD8⁺细胞产生γ干扰素
Eur J Immunol. 1993 May;23(5):1181-4. doi: 10.1002/eji.1830230532.
2
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.在皮肤利什曼病的小鼠模型中,γ干扰素调节Th1和Th2反应的早期发展。
J Immunol. 1991 Nov 1;147(9):3149-55.
3
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.在缺乏白细胞介素-12/23 p40的情况下,可获得疫苗诱导的针对亚马逊利什曼原虫的保护作用。
Immunol Lett. 2006 May 15;105(1):38-47. doi: 10.1016/j.imlet.2005.12.002. Epub 2006 Jan 13.
4
Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.遗传背景影响小鼠皮肤墨西哥利什曼原虫感染的免疫反应和疾病结局。
Int Immunol. 2005 Oct;17(10):1347-57. doi: 10.1093/intimm/dxh313. Epub 2005 Sep 2.
5
Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.亚马逊利什曼原虫:调节性T细胞和B细胞参与CBA/J脾细胞体外致敏(PIV)易感性反应。
Exp Parasitol. 2006 Jul;113(3):201-5. doi: 10.1016/j.exppara.2006.01.008. Epub 2006 Mar 3.
6
Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.分泌白细胞介素-4和γ-干扰素的CD4+细胞前体频率的变化与小鼠皮肤利什曼病病变的消退相关。
J Immunol. 1992 Oct 15;149(8):2715-21.
7
Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.体内去除L3T4 + T细胞后,基因易感小鼠对硕大利什曼原虫的细胞免疫和体液免疫
J Immunol. 1987 Aug 15;139(4):1303-9.
8
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.缺乏白细胞介素-12的基因抗性小鼠易受硕大利什曼原虫感染,并产生极化的Th2细胞反应。
Eur J Immunol. 1996 Jul;26(7):1553-9. doi: 10.1002/eji.1830260722.
9
Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.实验性皮肤利什曼病中CD8(+)和CD4(+) T细胞之间的相互作用:CD4(+) T细胞产生最佳干扰素-γ需要CD8(+) T细胞。
Parasite Immunol. 2003 Nov-Dec;25(11-12):559-67. doi: 10.1111/j.0141-9838.2004.00668.x.
10
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.美洲皮肤利什曼病患者对纯化的皮氏利什曼原虫无鞭毛体抗原和巴西利什曼原虫前鞭毛体抗原的T细胞反应性:与治愈相关的免疫模式
Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100.

引用本文的文献

1
T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.皮肤或黏膜利什曼病患者的T细胞介导的免疫反应:治疗后的长期评估
Clin Diagn Lab Immunol. 2002 Mar;9(2):251-6. doi: 10.1128/cdli.9.2.251-256.2002.
2
Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells.婴儿利什曼原虫感染的控制与CD8(+)以及产生γ干扰素和白细胞介素-5的CD4(+)抗原特异性T细胞相关。
Infect Immun. 1999 Nov;67(11):5559-66. doi: 10.1128/IAI.67.11.5559-5566.1999.
3
Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.
与人类皮肤利什曼病治愈相关的利什曼原虫反应性CD4+和CD8+ T细胞。
Infect Immun. 1994 Jun;62(6):2614-8. doi: 10.1128/iai.62.6.2614-2618.1994.